Earlier this year at the BioPharma Asia Convention, Hung-Jen Lai, MD Medical Director MSD Taiwan & Hong Kong delivered the presentation: âGaining Access to Key Asian Markets through Industry and Government Initiatives'
The presentation covers the following points:
- Which Asian markets are faster to approve NCEs?
- Which Asian markets have higher volume of clinical research?
- Which Asian market is faster to approve clinical trials?
- What are the advantages to gain quick access?
- Industry and government initiatives for access in Taiwan
- From research to patient commercialization: Taiwan case
The BioPharma Asia convention will be taking place again next year in March 2014. If you would like to find out more about this event, click here to visit the event website.